154 related articles for article (PubMed ID: 28128304)
21. Two novel polysaccharides from rhizomes of Cibotium barometz promote bone formation via activating the BMP2/SMAD1 signaling pathway in MC3T3-E1 cells.
Huang D; Hou X; Zhang D; Zhang Q; Yan C
Carbohydr Polym; 2020 Mar; 231():115732. PubMed ID: 31888819
[TBL] [Abstract][Full Text] [Related]
22. CKIP-1 knockout offsets osteoporosis induced by simulated microgravity.
Zhang X; Wang Q; Wan Z; Li J; Liu L; Zhang X
Prog Biophys Mol Biol; 2016 Nov; 122(2):140-148. PubMed ID: 27666961
[TBL] [Abstract][Full Text] [Related]
23. MiR-655-3p inhibits the progression of osteoporosis by targeting LSD1 and activating BMP-2/Smad signaling pathway.
Wang XJ; Liu JW; Liu J
Hum Exp Toxicol; 2020 Oct; 39(10):1390-1404. PubMed ID: 32431171
[TBL] [Abstract][Full Text] [Related]
24. Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway.
Liu S; Fang T; Yang L; Chen Z; Mu S; Fu Q
Int J Mol Med; 2018 Apr; 41(4):2059-2069. PubMed ID: 29393365
[TBL] [Abstract][Full Text] [Related]
25. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
26. Pulsed electromagnetic fields stimulate osteogenic differentiation and maturation of osteoblasts by upregulating the expression of BMPRII localized at the base of primary cilium.
Xie YF; Shi WG; Zhou J; Gao YH; Li SF; Fang QQ; Wang MG; Ma HP; Wang JF; Xian CJ; Chen KM
Bone; 2016 Dec; 93():22-32. PubMed ID: 27622883
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the Gut Microbiota and Barrier Function in Glucocorticoid-Induced Osteoporosis.
Schepper JD; Collins F; Rios-Arce ND; Kang HJ; Schaefer L; Gardinier JD; Raghuvanshi R; Quinn RA; Britton R; Parameswaran N; McCabe LR
J Bone Miner Res; 2020 Apr; 35(4):801-820. PubMed ID: 31886921
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
[TBL] [Abstract][Full Text] [Related]
29. miR-23b targets Smad 3 and ameliorates the LPS-inhibited osteogenic differentiation in preosteoblast MC3T3-E1 cells.
Liu H; Hao W; Wang X; Su H
J Toxicol Sci; 2016 Apr; 41(2):185-93. PubMed ID: 26961602
[TBL] [Abstract][Full Text] [Related]
30. Cmpk2 regulates mitochondrial function in glucocorticoid-induced osteoblast senescence and affects glucocorticoid-inhibited osteoblast differentiation.
Cao N; Wang Z; Huang C; Chen B; Zhao P; Xu Y; Tian Y
Arch Gerontol Geriatr; 2023 Nov; 114():105080. PubMed ID: 37269696
[TBL] [Abstract][Full Text] [Related]
31. Myricetin ameliorates glucocorticoid-induced osteoporosis through the ERK signaling pathway.
Fan S; Gao X; Chen P; Li X
Life Sci; 2018 Aug; 207():205-211. PubMed ID: 29883721
[TBL] [Abstract][Full Text] [Related]
32. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
[TBL] [Abstract][Full Text] [Related]
33. Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.
Kim JL; Park SH; Jeong D; Nam JS; Kang YH
Exp Biol Med (Maywood); 2012 Apr; 237(4):417-28. PubMed ID: 22496431
[TBL] [Abstract][Full Text] [Related]
34. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
35. Class I PI-3-Kinase Signaling Is Critical for Bone Formation Through Regulation of SMAD1 Activity in Osteoblasts.
Gámez B; Rodríguez-Carballo E; Graupera M; Rosa JL; Ventura F
J Bone Miner Res; 2016 Aug; 31(8):1617-30. PubMed ID: 26896753
[TBL] [Abstract][Full Text] [Related]
36. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid Suppresses Connexin 43 Expression by Inhibiting the Akt/mTOR Signaling Pathway in Osteoblasts.
Shen C; Kim MR; Noh JM; Kim SJ; Ka SO; Kim JH; Park BH; Park JH
Calcif Tissue Int; 2016 Jul; 99(1):88-97. PubMed ID: 26914606
[TBL] [Abstract][Full Text] [Related]
38. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro.
Suzawa M; Takeuchi Y; Fukumoto S; Kato S; Ueno N; Miyazono K; Matsumoto T; Fujita T
Endocrinology; 1999 May; 140(5):2125-33. PubMed ID: 10218963
[TBL] [Abstract][Full Text] [Related]
39. 2,4,5-Trimethoxyldalbergiquinol promotes osteoblastic differentiation and mineralization via the BMP and Wnt/β-catenin pathway.
Yun HM; Park KR; Quang TH; Oh H; Hong JT; Kim YC; Kim EC
Cell Death Dis; 2015 Jul; 6(7):e1819. PubMed ID: 26181200
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
